Cargando…
43.4 THE ROLE OF MOLECULAR IMAGING IN GUIDING DRUG DEVELOPMENT
BACKGROUND: Molecular imaging with Positron Emission Tomography (PET) has the unique capability of examining molecules in the brains of human subjects in real time. This has been well exploited in the study of dopaminergic transmission in schizophrenia. The results have on one hand confirmed some pr...
Autores principales: | Abi-Dargham, Anissa, Kegeles, Lawrence, Slifstein, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887534/ http://dx.doi.org/10.1093/schbul/sby014.182 |
Ejemplares similares
-
3.3 DISTURBANCES IN NEURAL OSCILLATIONS, GLUTAMATE, AND GABA: EFFECTS OF KETAMINE AND COMPARISON TO SCHIZOPHRENIA
por: Kegeles, Lawrence, et al.
Publicado: (2018) -
27. THE ROLE OF DOPAMINE IN SHAPING CIRCUITRY RELATED TO SCHIZOPHRENIA AND ADDICTION
por: Abi-Dargham, Anissa
Publicado: (2018) -
PET imaging of dopamine-D2 receptor internalization in schizophrenia
por: Weinstein, Jodi J., et al.
Publicado: (2017) -
Striatal Dopamine Release in Schizophrenia Comorbid with Substance Dependence
por: Thompson, Judy L., et al.
Publicado: (2012) -
434. Neurocysticercosis in Houston
por: McKenna, Megan, et al.
Publicado: (2018)